ChemoMetec Statistics

Total Valuation

ChemoMetec has a market cap or net worth of DKK 6.52 billion. The enterprise value is 6.29 billion.

Market Cap	6.52B
Enterprise Value	6.29B

Important Dates

The next estimated earnings date is Wednesday, September 11, 2024.

Earnings Date	Sep 11, 2024
Ex-Dividend Date	n/a

Share Statistics

ChemoMetec has 17.40 million shares outstanding. The number of shares has increased by 0.04% in one year.

Shares Outstanding	17.40M
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	51.53%
Float	17.35M

Valuation Ratios

The trailing PE ratio is 45.37 and the forward PE ratio is 44.33. ChemoMetec's PEG ratio is 3.17.

PE Ratio	45.37
Forward PE	44.33
PS Ratio	16.25
PB Ratio	13.07
P/FCF Ratio	49.40
PEG Ratio	3.17

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.74, with an EV/FCF ratio of 47.69.

EV / Earnings	43.76
EV / Sales	15.67
EV / EBITDA	32.74
EV / EBIT	34.87
EV / FCF	47.69

Financial Position

The company has a current ratio of 4.68, with a Debt / Equity ratio of 1.19.

Current Ratio	4.68
Quick Ratio	3.33
Debt / Equity	1.19
Debt / EBITDA	0.03
Debt / FCF	0.05
Interest Coverage	89.42

Financial Efficiency

Return on equity (ROE) is 30.09% and return on invested capital (ROIC) is 23.26%.

Return on Equity (ROE)	30.09%
Return on Assets (ROA)	19.61%
Return on Capital (ROIC)	23.26%
Revenue Per Employee	2.35M
Profits Per Employee	840,936
Employee Count	167
Asset Turnover	0.70
Inventory Turnover	0.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.02% in the last 52 weeks. The beta is 1.33, so ChemoMetec's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	-11.02%
50-Day Moving Average	367.10
200-Day Moving Average	375.15
Relative Strength Index (RSI)	48.97
Average Volume (20 Days)	29,911

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ChemoMetec had revenue of DKK 401.54 million and earned 143.80 million in profits. Earnings per share was 8.26.

Revenue	401.54M
Gross Profit	354.11M
Operating Income	180.44M
Pretax Income	183.43M
Net Income	143.80M
EBITDA	192.20M
EBIT	180.44M
Earnings Per Share (EPS)	8.26

Full Income Statement

Balance Sheet

The company has 232.15 million in cash and 5.95 million in debt, giving a net cash position of 226.20 million or 13.00 per share.

Cash & Cash Equivalents	232.15M
Total Debt	5.95M
Net Cash	226.20M
Net Cash Per Share	13.00
Equity (Book Value)	498.73M
Book Value Per Share	28.66
Working Capital	330.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 146.71 million and capital expenditures -14.76 million, giving a free cash flow of 131.96 million.

Operating Cash Flow	146.71M
Capital Expenditures	-14.76M
Free Cash Flow	131.96M
FCF Per Share	7.58

Full Cash Flow Statement

Margins

Gross margin is 88.19%, with operating and profit margins of 44.94% and 35.81%.

Gross Margin	88.19%
Operating Margin	44.94%
Pretax Margin	45.68%
Profit Margin	35.81%
EBITDA Margin	47.87%
EBIT Margin	44.94%
FCF Margin	32.86%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 1.58%.

Dividend Per Share	6.00
Dividend Yield	1.58%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	72.61%
Buyback Yield	-0.04%
Shareholder Yield	1.54%
Earnings Yield	2.20%
FCF Yield	2.02%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a